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Abstract
T cell development is critically dependent on both the environment and signals delivered by the T cell Receptor (TCR). The
Tec family kinase Itk has been suggested to be an amplifier of signals emanating from the TCR and the loss of Itk partially
affects most stages of thymopoiesis. Loss of Itk also differentially affects the development of conventional vs. non-
conventional or innate memory phenotype T cells. Here, we examine whether these lineage choices are affected by a
combination of TCR affinity and Itk by analyzing mice lacking Itk and carrying two TCR transgenes with differing affinities,
OT-II and DO11.10. Our results show that developing thymocytes receive a gradient of signals, DO11.10.OT-II.DO11.10/
Itk
2/2.OT-II/Itk
2/2. We also show that the development of CD4
+ T cells is controlled by TCR signaling via Itk, which
regulates the expression of the transcription factor, Th-POK, an enforcement factor for CD4 commitment. This results in a
reduction in CD4
+ T cell development, and an increase in the development of MHC class II restricted TCR transgenic CD8
+ T
cells that resemble non-conventional or innate memory phenotype CD8 T cells. This alteration accompanies increased
expression of Runx3 and its target genes Eomesodermin, Granzyme B and Perforin in Itk null OT-II CD4
+ thymocytes. All
together, these data suggest that Itk plays an important role in CD4/CD8 commitment by regulating signal thresholds for
the lineage commitment. Our data also suggest that the lower level of TCR signaling that occurs with a low affinity TCR in
the absence of Itk can redirect some MHC class II restricted CD4
+ T cell to class II-restricted CD8
+ innate memory phenotype
T cells.
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Introduction
Mature T cell development takes place in the thymus and is
critically dependent on signals through the TCR. During T cell
development, TCR signals generated by interaction with major
histocompatibility complex class (MHC)-II peptide complexes are
required for differentiation of CD4
+ T cells, while TCR signals
generated by interaction with class I MHC-peptide complexes are
required for differentiation of CD8
+ T cells. This process, referred
as CD4 and CD8 commitment, is a major developmental process
after positive and negative selection. While TCR signals are
important for this lineage, they are not completely clarified [1,2,3].
High signaling activity generated by the tyrosine kinase Lck or
MAP kinases ERK1/2 enhances CD4 Single Positive (SP)
development [4,5], while low activity of Lck, ZAP70 or ERK1/
2 leads to CD8 SP development [4,5,6]. These findings support
the idea that attenuating TCR signaling could redirect thymocytes
with class II restricted TCRs from CD4 to the CD8 lineage, while
enhanced signaling could redirect thymocytes with class I specific
TCRs from CD8 to CD4 lineage. Other evidence indicates that
the duration of signaling as well as the number of TCRs triggered
are key factors in determining CD4/CD8 T cell fate decision
[7,8]. A role for TCR affinity has not been implicated in these
events, but may play a role dependent on whether TCR affinity
affects these implicated signaling events.
The IL-2-inducible T cell kinase (Itk), a Tec family kinase,
regulates TCR signals and is considered an amplifier of these
signals in T cells [9,10,11,12]. Itk is directly activated by Lck and
in turn plays a role in the activation of PLCc1, Ca
2+mobilization
and activation of ERK/MAPK [13]. Itk-deficient mice had
decreased numbers of mature thymocytes [14,15,16], and exhibit
altered thymopoiesis, including pre-TCR signaling, as well as
positive and negative selection [15,17,18,19]. Based on these
observations and the important roles of other TCR signaling
proteins such as Lck and ZAP70 in the CD4/CD8 commitment, it
seems likely that the Itk may also influence CD4/CD8
commitment [20]. However, Berg and colleagues have examined
this issue by crossing Itk deficient mice to mice carrying the AND
MHC class II restricted TCR, along with different MHCs that had
varying affinities for TCR, and observed that while Itk affects
positive selection and development of CD4 SP thymocytes, CD8
SP thymocyte development is not affected, suggesting that the Itk
signaling is not involved in the lineage commitment [18].
However, these experiments did not rule out the possibility that
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8891signals in the TCR transgenic systems used in this study may be
above a certain threshold that, even in the absence of Itk, does not
affect CD4 and CD8 lineage commitment.
We and others have recently reported that large majority of
CD8
+ T cells in mice lacking Itk have the characteristics of
memory cells and innate immune cells [21,22,23,24,25]. These
cells have been referred to as ‘‘non-conventional CD8
+ T cells’’ or
‘‘innate memory phenotype cells’’. By contrast, cells carrying the
surface phenotype of naı ¨ve CD8
+ T cells have the characteristics of
conventional CD8
+ T cells, and are drastically reduced in the
absence of Itk. These data suggest that Itk modulated signals may
regulate the development of specific subpopulations of CD8
+ T
cells. However, it is not clear if these CD8
+ T cells develop because
they are destined to become CD8
+ T cells, and the Itk signals
regulate whether they develop into conventional or non-conven-
tional CD8
+ T cells, or whether Itk signals regulate the
development of these cells regardless of their initial cell fate
choice. Here, we have analyzed mice lacking Itk and carrying two
low affinity TCR transgenes specific for a peptide derived from
Ovalbumin (OT-II mice, DO11.10, presented by different
respective MHC class II molecules in C57BL/6 and BALB/c
mice), to determine if cells destined to become class II restricted
CD4
+ T cells are affected by the absence of Itk [26]. Our results
show that compared to thymocytes developing in DO11.10/
Itk
2/2 mice, thymocytes in OT-II/Itk
2/2 mice receive reduced
TCR signals, with reduced development of ‘‘naı ¨ve’’ transgenic
CD4
+ T cells, and subsequent development of significant numbers
of peptide specific MHC class II restricted TCR transgenic CD8
+
T cells. Furthermore, a large majority of these TCR transgenic
CD8
+ T cells have the characteristics of non-conventional or
innate memory phenotype CD8
+ T cells. We also show that the
absence of Itk affects the expression of Th-POK (T help inducing
POK factor), Runx3 (runt-related transcription factor 3) and TOX
(thymocyte selection-associated HMG box), transcription factors
that regulate the development of CD4 and CD8
+ T cells. These
data indicate that the absence of Itk allows the development of
non-conventional CD8
+ T cells even if they carry a class II
restricted TCR, and suggest that the development of these cells is
regulated in part by altered signals from this low affinity TCR.
Altered development of CD4
+ naı ¨ve T cells in the absence of Itk
may be a consequence of reduced TCR signaling, resulting in
reduced expression of the transcription factor, Th-POK, a master
regulator of CD4 commitment, and increased expression of Runx3
with accompanying changes in cell fate decision.
Results
The Absence of Itk Results in Reduced Development of
CD4
+ T Cells
We compared the development of CD4 and CD8 single-positive
(SP) T cells in the thymi of mice lacking Itk and found, as
previously reported, that the absence of Itk results in reduced
percentages of CD4 SP T cells, with an increase in the percentage
of CD8 SP T cells (Fig. 1a) [27,28,29,30,31,32]. Gating on the
more mature TCR
hi cells illustrates this point more keenly, with a
significant reduction in TCR
hi CD4 SP cells in mice lacking Itk,
and an increase in TCR
hi CD8 SP cells. As we and others have
previously reported, this alteration in the percentages of CD4 and
CD8 SP cells reflects reduced numbers of TCR
hi CD4 single
positive cells, with an increase in TCR
hi CD8 SP cells (Fig. 1b).
We next performed fetal thymic organ cultures to determine if
this alteration in development is due to alterations in the timing of
development of these cells. Figure 2 demonstrates that compared
to WT thymocytes, those lacking Itk exhibited reduced develop-
ment of CD4SP T cells in vitro, with increased percentage of CD8
SP T cells developing (Fig. 2a). These data demonstrate that the




Further analysis of transgenic mice carrying WT or a kinase
domain deleted mutant of Itk in a T cell specific fashion illustrates
that kinase activity of Itk is required for efficient development of
these T cells. Gating on mature TCR
hi thymocytes we compared
Itk null mice carrying a WT Itk transgene (Tg(CD2-Itktg)Itk
2/2) to
WT mice, and found that WT Itk was able to rescue the ratio of
CD4 to CD8 T cells, particularly in the TCR
hi SP population
(Fig. 2b). By contrast, the previously described kinase domain
deleted mutant Itk (Tg(Lck-ItkDKin)Itk
2/2) [27], was unable to
rescue the ratio of CD4 to CD8 T cells. In the experiments
detailed below, we further characterize the role of Itk in the
development of CD4
+ T cells, and return to CD8
+ T cells later in
this report.
The Absence of Itk Results in Reduced Development of
OT-II Transgenic CD4
+ T Cells
Previous analysis of the role of Itk in T cell development using
TCR transgenes that drive CD4
+ T cell development have not
revealed a role in CD4 or CD8 lineage commitment [15,16].
However, these transgenes may have had affinities for antigen that
were high enough to overcome any differences. Therefore to
determine if reduced TCR signals due to the absence of Itk can
influence CD4 lineage development, we crossed Itk
2/2 mice to
TCR transgenic OT-II mice. OT-II mice carry a transgenic ab
TCR (Va2/Vb5) that recognizes ovalbumin 323–339 in the
context of MHC class II I-A
b with low affinity [26,33]. Greater
than 95% of TCR transgene positive T cells are CD4
+ T cells
(Fig. 3a, see figure S1 for TCR transgene expression profiles).
However, the absence of Itk in OT-II mice dramatically reduced
the development of CD4 SP cells, accompanied by the
development of a significant percentage of CD8 SP cells that
were positive for the TCR transgene TCR positive (Fig. 3a). This
resulted in a ratio of CD4:CD8 TCR transgene positive cells of 0.7
in OT-II/Itk
2/2 mice, compared to 70 for the WT OT-II mice, a
change of greater than 100 fold.
In the lymph node, the ratio of CD4:CD8 TCR transgenic T
cells was 37 in the WT OT-II mice compared to 1.5 in the OT-II/
Itk
2/2 mice, a change of 25 fold (Fig. 3c). These data suggest that
Itk is essential for the development of OT-II thymocytes into CD4
lineage cells. Our data also suggest that in the absence of Itk,
developing double positive (DP) thymocytes may have a slight
preference for becoming CD8 SP cells, a point we will discuss
further later.
Although the OT-II/Itk
2/2 mice showed a 3–4 fold reduction
in total thymocytes that were TCR transgene positive compared to
OT-II mice (data not shown), the number of TCR transgene
positive CD8 SP thymocytes was increased 2–3 fold, while that of
CD4 SP thymocytes was reduced 5–6 fold (Fig. 3b). This
difference between WT and Itk
2/2 TCR transgene positive CD4
SP cells was more exaggerated in the lymph node, where we
observed a 15–16 fold reduction (Fig. 3d). This could be the result
of reduced homeostatic expansion of transgene positive CD4
+ T
cells in the absence of Itk after migrating into periphery, as this
was observed in the non-transgenic mice when naı ¨ve T cells from
Itk
2/2 mice were transferred into RAG
2/2 mice (data not
shown). In addition, the increase in TCR transgene positive CD8
+
T cells observed in Itk
2/2 mice was less pronounced in the lymph
node, with a ,1.5 increase compared to WT OT-II mice (Fig. 3d,
similar results were seen in the spleen, data not shown).
Itk Regulates ThPOK Expression
PLoS ONE | www.plosone.org 2 January 2010 | Volume 5 | Issue 1 | e8891Figure 1. The absence of Itk affects the development of CD4 and CD8 T cells. (A) Thymocytes from WT or Itk
2/2 mice were analyzed for
expression of CD4 and CD8 (left), or gated first on the TCR
hi population and analyzed for CD4 and CD8 (right). (B) The number of thymocytes (total,
left) or TCR
hi thymocytes (right) in WT and Itk
2/2 mice. *p,0.05, n=3–5 mice.
doi:10.1371/journal.pone.0008891.g001
Figure 2. (A) Fetal Thymic Organ Culture analysis of WT and Itk
2/2 thymocyte development. FTOC from embryonic day 16 of WT and Itk
null mice incubated in vitro for the indicated days, gated on TCR
hi and analyzed for CD4 and CD8 (data representative of 3–4 mice). (B) Active Itk
kinase activity is required for T cell development. Thymocytes from WT, Itk
2/2, Tg(Lck-ItkDKin)Itk
2/2 and Tg(CD2-Itktg)Itk
2/2 mice were gated
first on the TCR
hi and analyzed for expression of CD4 and CD8.
doi:10.1371/journal.pone.0008891.g002
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Development of DO11.10 Transgenic CD4
+ T Cells
We next asked whether the affinity of the TCR was important
for our finding of a significant role for Itk in CD4
+ T cell
development. The OT-II transgenic TCR is a low affinity TCR,
and recognizes the same antigen as the transgenic TCR carried by
DO11.10 transgenic mice, albeit presented by a different MHC
class II molecule [26]. The DO11.10 TCR carries the transgenic
ab TCR (Va13/Vb8) that also recognizes ovalbumin 323–339,
however, in the context of MHC class II I-A
d and has
approximately 50 fold higher affinity for antigen than OT-II
[26,33]. We therefore determined if the absence of Itk on the
DO11.10 transgenic background would have less of an effect on
CD4
+ and CD8
+ T cell development.
To this end, we analyzed Itk
2/2 mice crossed to TCR
transgenic DO11.10 mice. Supporting the view that the affinity
of the TCR is critical for the function of Itk in the development of
CD4
+ T cells, the absence of Itk had less of an effect on the
development of CD4 SP cells in DO11.10 mice with the higher
affinity TCR (Fig. 4a, see figure S1 for TCR transgene
expression profiles). This resulted in a ratio of CD4:CD8 TCR
transgene positive of ,162 in WT DO11.10 mice, compared to
,50 for the DO11.10/Itk
2/2 mice, a change of ,3 fold. This was
also reflected in the numbers of these cells (,4 fold difference in
CD4SP cell number, Fig. 4b).
In the lymph nodes of the DO11.10 mice, the TCR transgene
positive CD4:CD8 ratio was ,14.7 compared to ,3.6 in the
DO11.10/Itk
2/2 mice, a change of ,4 fold (Fig. 4c). This was
also reflected in the numbers of these cells (,3.5 fold difference in
CD4SP cell number, Fig. 4d). These data suggest that the affinity
of the TCR is critical in determining whether Itk will be important
for the development of CD4
+ thymocytes, and that a high affinity
TCR can partially or fully compensate for the lack of Itk in CD4
+
thymocyte development.
Interaction between TCR Affinity and Itk Derived Signals
Regulate the Development of CD4
+ T Cells
Our results so far analyzing the cross between TCR affinity and
Itk expression suggest that higher affinity TCR could partially
compensate for the absence of Itk for the development of CD4
+ T
cells. To explore this point further, we analyzed the ratios of the
numbers of transgene positive CD4SP thymocytes in the two
transgenic mouse strains, and their Itk null counterparts.
Comparing the higher affinity DO11.10 mice to OT-II mice
revealed that DO11.10 mice generated more CD4SP thymocytes
as expected for thymocytes that have higher affinity TCRs and
thus better able to be selected (expectation of 1 if DO11.10 and
OT-II mice have equal ability to generate CD4SP thymocytes,
actual ratio, 5.3, Fig. 5a). More strikingly, comparing the
transgenic counterparts lacking Itk revealed that DO11.10 mice
Figure 3. The absence of Itk affects the development of CD4
+ T cells in OT-11 transgenic mice. (A) Total thymocytes (left panels) or the
transgenic TCR
+ (Va2/Vb5) population from OT-II and OT-II/Itk
2/2 mice analyzed for expression of CD4 and CD8 (right panel). (B) The number of
thymocytes (total, left) or transgene TCR
hi thymocytes (right) in WT and Itk
2/2 mice. *p,0.05, n=3–5 mice. (C) Total lymphocytes (left panel) or the
transgenic TCR
+ (Va2/Vb5) population (right panel) from cervical lymph nodes of OT-II and OT-II/Itk
2/2 mice analyzed for expression of CD4 and CD8.
(D) The number of total lymphocytes (left) or the transgene TCR
+ T cells from cervical lymph nodes (n=3–5, *p,0.05).
doi:10.1371/journal.pone.0008891.g003
Itk Regulates ThPOK Expression
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OT-II mice lacking Itk (ratio 29.7, Fig. 5a). This suggests that the
affinity of the DO11.10 TCR had a significant effect in
overcoming the absence of Itk.
Comparing the effect of Itk within strains, we found that OT-II
mice generated ,22 fold more CD4SP thymocytes than OT-II
mice lacking Itk, while DO11.10 mice had a markedly reduced
advantage, only generating ,5 fold more CD4SP thymocytes than
DO11.10 mice lacking Itk (Fig. 5a). Similar conclusions could be
made if the ratio of the percentages of CD4SP thymocytes are
compared (Fig. 5b). Together, these data suggest that the affinity
of the TCR interacts with those TCR signals regulated by Itk to
generate CD4SP thymocytes.
Reduced TCR Signaling in the Absence of Itk during T
Cell Development
Our results so far suggest that TCR affinity and signals
regulated by Itk interact to regulate the development of CD4
+ T
cells. Previous analysis of Itk
2/2 mice suggests that their T cells
receive weak TCR signals, and that Itk may act as an amplifier of
T cell receptor signals [9,10,11,12]. CD5 surface expression on
mature SP thymocytes and T cells has been found to directly
parallel the signaling intensity received by developing thymocytes
[34]. Indeed, as shown in figure 6, CD5 expression was lower in
non-transgenic total DP thymocytes from Itk
2/2 mice compared
to WT mice (Fig. 6a). In addition, in the OT-II transgenic mouse
system, CD5 levels were also reduced in the TCR
hi DP
thymocytes and CD4 SP thymocytes, but less so on CD8 SP
thymocytes (Fig. 6a). Similar analysis of the DO11.10 transgenic
mouse system revealed that CD5 levels were also reduced in the
TCR
hi DP thymocytes and CD4 SP thymocytes, but not on CD8
SP thymocytes. However, the reduction in CD5 expression was
not as profound as that seen in the OT-II system (Fig. 6a).
Rescaling these data revealed that the ratio of CD5 expression on
DP thymocytes between WT:Itk
2/2 in the two TCR transgenic
systems was much higher in the lower affinity OT-II system
compared to the DO11.10 system, supporting the view that the
differences in development in CD4 SP cells between DO11.10 and
OT-II may be due to the level of signals received by developing T
cells (Fig. 6b). This difference in signal strength also correlated
with the level of development of CD8 SP cells between the WT
and Itk
2/2 transgenic systems (i.e. higher ratio of WT:Itk
2/2 and
more development of transgene positive CD8
+ T cells in the
absence of Itk, Fig. 6b). These data confirmed that developing DP
thymocytes receive weak signals from the TCR in the absence of
Itk. This reduced signal may lead to the reduction in CD4
+ T cell
development, and perhaps an increase in CD8
+ T cells.
Normal Survival of CD4SP and CD8SP TCR Transgenic
Thymocytes in the Absence of Itk
OT-II and OT-II/Itk
2/2 mice showed the largest difference in
CD4SP numbers and percentages both thymus and periphery. We
therefore determined if the absence of Itk alters the survival of
thymocytes in this background. Since Bcl-2 is a prominent survival
Figure 4. The absence of Itk affects the development of CD4
+ T cells in DO11.10 transgenic mice. (A) Total thymocytes (left panels) or
the transgenic TCR
+ (KJ-11
+) population from DO11.10 and DO11.10/Itk
2/2 mice analyzed for expression of CD4 and CD8 (right panel). (B) The
number of thymocytes (total, left) or transgene TCR
hi thymocytes (right) in WT and Itk
2/2 mice. *p,0.05, n=3–5 mice. (C) Total lymphocytes (left
panel) or the transgenic TCR
+ population (right panel) from cervical lymph nodes of DO11.10 and DO11.10/Itk
2/2 mice analyzed for expression of
CD4 and CD8. (D) The number of total lymphocytes (left) or the transgene TCR
+ T cells from cervical lymph nodes (n=3–5, *p,0.05).
doi:10.1371/journal.pone.0008891.g004
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death in T cells, and is required for prolonged lymphocyte survival
following maturation [35], we examined the expression of Bcl-2 in
thymocytes from OT-II and OT-II/Itk
2/2 mice. We found that
the levels of Bcl-2 was low in total OT-II DP thymocytes, and was
up-regulated in TCR
hi DP thymocytes, remaining high in TCR
hi
CD4 and CD8 SP thymocytes, and OT-II/Itk
2/2 thymocytes
behaved similarly (Figure S2). Similarly, there was no difference
in annexin V staining between OT-II and OT-II/Itk
2/2 mice,
suggesting no difference in death in thymocytes from these mice
(Figure S3).
Itk Regulates the Development of Naı ¨ve TCR Transgenic
CD4
+ T Cells
We and others have recently shown that the absence of Itk
preferentially affects the development of naı ¨ve CD4




lo), with little effect on populations of CD4
+




hi, preformed IFNc message and ability to rapidly
secrete this cytokine [21,22,23,24,25]). It is not clear if the
transgene positive CD4
+ cells that develop in the absence of Itk are
of the ‘‘naı ¨ve’’ or ‘‘innate memory phenotype’’. We therefore
analyzed the populations of T cells that developed in the TCR
transgenic mice to determine their phenotype. We found that
regardless of the affinity of the TCR, the percentage of naı ¨ve
CD4
+ T cells (i.e. CD4
+CD62L
hiCD44
lo) in the periphery of these
mice was similar if the mice lacked Itk (Fig. 7a, b). However, as
seen in figures 3 and 4, OTII/Itk
2/2 mice have much fewer
CD4
+ T cells overall (Figs. 3d, 4d).
By contrast both OT-II and DO11.10 mice generate similar
numbers of transgene positive CD4
+CD62L
hiCD44
lo (naı ¨ve) T
cells, and in both cases, the absence of Itk significantly affects the
development of these cells (Fig. 7c). However, the lower affinity
OT-II transgenic T cells are significantly more affected than the
DO11.10 transgenic T cells (Fig. 7c). A similar effect is observed




(memory phenotype) T cells (Fig. 7c). Thus the affinity of the
TCR has more of an effect on the number of CD4
+ T cells that
develop, than on the percentage of those cells that have a
‘‘memory phenotype’’. By contrast, Itk affects both parameters.
Itk Interacts with TCR Affinity to Regulate the
Development of ‘‘Nonconventional’’ (or Innate Memory
Phenotype) TCR Transgenic CD8
+ T Cells
We and others have recently shown that CD8
+ T cells that have
a memory phenotype and show innate function (‘‘non-conven-
tional’’ T cells) also develop in an Itk independent manner
[22,23,25]. Here, we also observed that the absence of Itk led to an
increase in percentage (and number) of CD8
+ T cells that bear the
OT-II transgenic TCR (Fig. 3). However, there was significantly
lower percentage of TCR transgene positive CD8
+ T cells in
DO11.10 mice (Fig. 4). We therefore further analyzed those cells
developing in the OT-II background, and find that the transgenic
TCR
hiCD8
+ SP thymocytes that develop in OT-II/Itk
2/2 have
phenotypes similar to CD8
+ SP thymocytes of non-transgenic
Itk
2/2 mice, including high levels of CD44 and CD122, while
WT OT-II mice have a much lower frequency of these cells
(Fig. 8a). These CD8
+ T cells were also able to rapidly produce
IFN-c upon ex vivo stimulation with PMA/Ionomycin (Fig. 8b).
These TCR
hi CD8
+ T cells could respond to the MHC class II
restricted antigen (OVA323–339 peptide) recognized by the
transgenic TCR when cultured in the presence of this peptide
(total splenocytes were used due to the difficulty in isolating the
small number of TCR
hiCD8
+ T cells from these TCR transgenic
mice). After 7 days of culture cytokine secretion from the
transgenic TCR
hiCD8
+ cells was analyzed by restimulation of




2/2 mice, but not those cells from OT-II
mice, produced IFN-c after MHC class II-restricted OVA




+ cells did not respond to the specific peptide
stimulation, but instead to cytokines and other factors produced
by activated CD4
+ T cells in the culture. We think this is unlikely
as WT CD4
+ T cells respond very well to the OVA peptide, yet
the CD8
+ Tg
+ T cells did not respond to peptide restimulation in
those cultures. These CD8
+ T cells are restimulated with the OVA
peptide followed by analysis of intracellular IFN-c, indicating that
the Itk
2/2 cells can respond to this peptide for cytokine secretion,
whereas WT CD8
+ T cells cannot. We also note that the few
CD8
+ transgene positive cells found in WT OT-II that produce
IFN-c in response to PMA/Ionomycin stimulation do not respond
to the OVA peptide when restimulated in vitro (Fig. 8b, c). These
data suggest that the transgenic TCR
hiCD8
+ T cells that develop
in OT-II/Itk
2/2 mice are likely MHC class-II restricted and can
be activated by class II-restricted peptide, but bear the hallmarks
of ‘‘non-conventional’’ or ‘‘innate memory phenotype’’ CD8 T
cells.
Reduced Expression of the CD4 Lineage Commitment
Factor, Th-POK, in Itk Null DP Thymocytes
A large body of evidence supports the view that the amount of
TCR signaling determines the lineage commitment decisions for
development of the CD4 and CD8 T cells. The nature of the
signals that affect changes in gene expression that specify the
CD4/CD8 T cell lineage commitment and enforcement has
become a major goal of work in this area. Several transcription
Figure 5. TCR affinity and Itk signals regulate the number of
CD4SP cells that develop. (A) The ratio of the number of CD4SP
thymocytes between the indicated mouse strains were plotted. (B) The
ratio of the percentages of CD4SP thymocytes between the indicated
mouse strains were plotted.*p,0.05, n=3–5 mice.
doi:10.1371/journal.pone.0008891.g005
Itk Regulates ThPOK Expression
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been identified, including the Runx factors, as well as TOX,
GATA3 and Th-POK [36,37,38,39,40,41,42,43]. Among these
transcription factors, Th-POK has been identified as a master
enforcer of CD4 commitment [44,45,46,47]. Th-POK is a Zn
finger transcription factor, and is expressed specifically in the
CD4 lineage. Enforced constitutive expression of Th-POK not
only leads to normal development of MHC class II-restricted T
cells to the CD4 lineage but also causes redirection of MHC class
I-restricted cells to the CD4 lineage [46,48]. Notably, however,
signals that regulate the expression of Th-POK and thus CD4
lineage commitment are less clear. Our data suggest that the
absence of Itk affects the strength of signal through the TCR and
thus the development of CD4SP (and potentially CD8SP) in an
environment of enforced MHC class II-restriction. To determine
if these reduced signals regulate the transcription factors that
modulate CD4/CD8 lineage commitment, we analyzed sorted
transgenic TCR
hi DP thymocytes from OT-II, OT-II/Itk
2/2,
DO11.10 and DO11.10/Itk
2/2 mice, and determined the
expression levels of different transcription factors using quantita-
tive real-time RT-PCR. As shown in figure 9, Th-POK
expression in OT-II/Itk
2/2DP thymocytes was significantly
lower than those from OT-II mice (Fig. 9a). By contrast, the
level of Th-POK expression in DO11.10/Itk
2/2 mice was closer
Figure 6. The strength of the TCR signal is reduced in the absence of Itk. (A) Thymocytes from non-transgenic WT, Itk
2/2 mice, TCR
transgenic OT-II and OT-II/Itk
2/2, or TCR transgenic DO11.10 and DO11.10/Itk
2/2 mice were stained with CD4, CD8a, TCR (or transgenic TCR) and
CD5. Histograms of CD5 expression on DP, transgenic TCR
hiDP, transgenic TCR
hiCD4SP and transgenic TCR
hiCD8SP from WT (solid lines), Itk
2/2
(dashed lines) are shown. A minimum of 6 mice of each genotype with 6–12 weeks of age were analyzed, and representative flow profiles are shown.
(B) The ratios of the mean fluorescence intensities (MFI) for CD5 for WT:Itk2/2 TCR transgenic mice are indicated for double positive and CD4 and
CD8 single positive thymocytes. *p,0.05, n=3–5 mice.
doi:10.1371/journal.pone.0008891.g006
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the differences in affinity and signal strength (as detected by CD5
expression, see Fig. 6). Examining theratio of expressionbetween
WT and Itk
2/2 revealed that like CD5 expression, expression of
Th-POK was regulated by Itk and TCR affinity (Fig. 9c,i.e. the
ratio is larger between the lower affinity OT-II and OT-II/Itk
2/2
DP thymocytes). Given the role of this factor in regulating the
development of CD4 SP thymocytes, these data suggest that the
strength of the TCR signal that thymocytes receive regulate the
expression of Th-POK, and thus CD4
+ T cell development.
Analysis of the percentage of CD69
+ cells in WT and OT-II and
OT-II/Itk
2/2 DP thymocytes did not reveal any differences in
expression, suggesting that differences in DP thymocytes that
have received differentiation signals (and are CD69
+), does not
explain the observed differences in Th-POK expression (see
figure S4).
We also analyzed the levels of Runx3, which has been shown to
bind to the CD8 enhancer and contribute to CD8 expression in
CD8SP and mature CD8 lineage T cells [38]. Runx3 has also
been suggested to negatively regulate Th-POK expression [49].
Figure 9 shows that the level of Runx3 is higher in OT-II/Itk
2/2
DP thymocytes compared to cells from OT-II (Fig. 9a). By
contrast DO11.10/Itk
2/2 DP thymocytes had the reverse pattern,
with the WT counterparts expressing higher levels of Runx3
compared to the Itk null animals, a point made more evident when
the WT:Itk
2/2 ratios are compared (Fig. 9c). The significance of
this difference is unclear, since Th-POK expression and genetic
programming for CD4 T cell development is inhibited by Runx-
dependent silencer activity [49]. Similarly, analysis of GATA3
revealed that the difference in expression between OT-II and OT-
II/Itk
2/2 DP thymocytes was smaller compared to the higher
affinity DO11.10 and DO11.10/Itk
2/2 thymocytes (Fig. 9a, b &
c). GATA3 has been shown to regulate CD4 T cell development
and may regulate Th-POK expression [41,42,43]. By contrast,
while no significant difference was observed in levels of TOX in
the OT-II transgenic system, TOX expression was reduced in the
DO11.10 mice compared to DO11.10/Itk
2/2 mice (Fig. 9a, b,
c).
Figure 7. Reduced development of naı ¨ve TCR transgene positive CD4
+ T cells in OT-II/Itk
2/2 and DO11.10/Itk
2/2 mice. (A) CD4
+/
transgene TCR
+ splenocytes from OT-II, OT-II/Itk
2/2, DO11.10 and DO11.10/Itk
2/2 mice were analyzed for CD44 and CD62L. (B) The percentages of
TCR transgene, CD4, CD44
hi and CD62L




hi as well as CD4
+CD62L
hiCD44
lo T cells for each genotype is indicated.
doi:10.1371/journal.pone.0008891.g007
Itk Regulates ThPOK Expression
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affinity and Itk signals in regulating CD4SP development, we
rescaled the data for Th-POK, and compared the ratios of
expression Th-POK to the ratios of CD4SP in the two transgenic
systems. Revealingly, there was a significant relationship between
the ratio of expression of Th-POK in the TCR transgenic
thymocytes, and their development of CD4SP cells. Thus the
larger difference in expression of Th-POK between OT-II and
OT-II/Itk thymocytes was associated a larger difference in the
percentage of CD4SP cells compared to the DO11.10 system
(Fig. 10a). Together, these data suggest that a combination of
TCR affinity and signals derived from Itk regulate Th-POK
expression, thus modulating the development of CD4
+ T cells.
We also determined Th-POK expression in conventional
(CD44
lo/CD62L
hi) CD4SP thymocytes and peripheral CD4
+ T
cells. We find that unlike DP thymocytes, there was no difference
in expression of Th-POK (Fig. 10b). Our interpretation of this
finding is that those Itk
2/2 cells that express a threshold level of
Th-POK are allowed to differentiate, but this frequency is much
lower than that seen in the WT mice, hence the reduced numbers
of mature CD4SP in the absence of Itk. Indeed, analysis of Th-
POK expression in non-transgenic WT and Itk
2/2 DP thymo-
cytes revealed no significant differences in expression, perhaps due
to the range of TCRs with different affinities in a non-transgenic
background that may allow signaling of appropriate Th-POK
expression (Fig. 10b).
Elevated Expression of Runx Targets Genes in Itk Null
CD4SP Thymocytes
The altered expression of Th-POK in the absence of Itk, and
the elevated Runx3 expression in the low affinity OT-II TCR
transgenic system prompted us to determine whether downstream
targets of Runx3 are affected in the absence of Itk. We therefore
analyzed the expression of Eomesodermin, Granzyme B and
Perforin in conventional (CD44
loCD62L
hi) CD4SP thymocytes in
the presence and absence of Itk in the OT-II transgenic system (to
rule out potential contributions from Memory Phenotype (MP)
CD4SP cells [27]). We find that the absence of Itk in the CD4SP
OT-II transgenic thymocytes results in elevated expression of
Eomesodermin, Granzyme B and Perforin, suggesting that
reduced Th-POK expression may unleashed the function of Runx
proteins in driving the expression of these genes (Fig. 11).
Discussion
This study was designed to examine whether CD4/CD8 lineage
choices are affected by the reduced TCR signals in the absence of
Itk. We analyzed Itk
2/2 mice crossed to mice carrying two TCRs
reactive against ovalbumin, the low affinity MHC class II-
restricted transgenic TCR (OT-II) and the higher affinity (50
fold) MHC class II-restricted transgenic TCR (DO11.10). Our
results show that dependent on the affinity of the TCR, Itk affects
the development of naı ¨ve CD4
+ T cells. Our results also suggest
that this occurs via Itk mediated (direct or indirect) regulation of
Th-POK expression, suggesting that the strength of the TCR
signal modulates Th-POK expression and thus CD4
+ T cell
development. Finally, our results suggest that by modulating Th-
POK expression, Itk derived signals affect the expression of CD8
patterning genes such as Runx3, which regulates the expression of
Eomesodermin, Granzyme B and Perforin in naı ¨ve or conven-
tional CD4SP thymocytes, altering the potential response of these
T cells. Finally, our results suggest that at significantly reduced
TCR affinity, ‘‘non conventional’’ CD8
+ T cells begin to develop.
Berg and colleagues have previously used a TCR transgenic
approach to analyze the role of Itk in CD4 and CD8 T cell
commitment [18]. They analyzed three different lines of MHC class
II-restricted TCR transgenics, 2B4, 5C.C7 and AND, all lacking Itk
and found a significant difference in the number of CD4SP T cells,
although there was not much difference in CD8SP T cells based on
Figure 8. TCR transgene positive CD8 T cells that develop in
OT-II/Itk
2/2 have characteristics of ‘‘non-conventional’’ or
‘‘innate memory phenotype’’ CD8 T cells. (A) TCR transgene
positive CD8SP thymocytes from OT-II or OT-II/Itk
2/2 were analyzed for
CD44 or CD122 by flow cytometry. (B) Splenocytes from OT-II or OT-II/
Itk
2/2 mice were stimulated with PMA and Ionomycin for 6 hours,
followed by analysis of TCR transgene positive CD8
+ T cells for
expression of CD44 and IFN-c.( C) Splenocytes from OT-II or OT-II/Itk
2/2
mice were stimulated with OVA peptide in vitro, followed by analysis of
TCR transgene positive CD8
+ T cells for expression of IL-4 or IFN-c.
doi:10.1371/journal.pone.0008891.g008
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PLoS ONE | www.plosone.org 9 January 2010 | Volume 5 | Issue 1 | e8891Figure 9. Itk mediated signals regulate the expression of the CD4 lineage commitment factor Th-POK. (A) Quantitative real-time RT-PCR
for Th-POK, TOX, Runx3 and GATA3 in sorted transgenic TCR
hi DP thymocytes from OT-II and OT-II/Itk
2/2 mice. Data are corrected for GAPDH
expression and expressed as fold over mRNA of the transgenic TCR
hi DP derived from OT-II mice, which was set at 1 (n=3, *p,0.05). The experiment
was repeated 2X with the same results. (B) Quantitative real-time RT-PCR for Th-POK, TOX, Runx3 and GATA3 in sorted transgenic TCR
hi DP
thymocytes from DO11.10 and DO11.10/Itk
2/2 mice Data are corrected for GAPDH expression and expressed as fold over mRNA of the transgenic
TCR
hi DP derived from DO11.10 mice, which was set at 1 (n=3, *p,0.05). The experiment was repeated 2X with the same results. (C) Data used to
generate (A) and (B) were rescaled to generate ratios of either OT-II:OTII/Itk
2/2 or DO11.10:DO11.10/Itk
2/2 mRNA expression levels for Th-POK,
Runx3, GATA3 and TOX.
doi:10.1371/journal.pone.0008891.g009
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our results, we suggest that the strength of the TCR intersects with
Itk signals to reach specific thresholds (such as Th-POK expression)
for CD4 lineage commitment/enforcement. Those few Itk null
CD4
+ T cells that receive a high enough signal could express the
appropriate levels of Th-POK and are allowed to continue their
differentiation, which occurs at much reduced frequency in the
absence of Itk. Previous analysis of the DO11.10 MHC class II-
restricted TCR in the absence of active Lck did not reveal altered
CD4 and CD8 development [50]. However, Alberola-Ila and
colleagues showed that functional CD8
+ T cells develop in mice
transgenic for the MHC class II-restricted AND TCR when Lck
activity was reduced, suggesting that the magnitude of the reduction
in TCR signals may be important for this effect [4,51].
Our analysis of genes that regulate the expression of CD4 and
CD8 lineage commitment in double positive thymocytes revealed
that Itk mediated signals regulate the expression of Th-POK,
previously identified as a major enforcer of CD4 T cell commitment
[24–26][43]. Similarly, the expression of GATA3, another regulator
of CD4 T cell commitment was significantly reduced in low affinity
OT-II/Itk
2/2 TCR transgenic DP thymocytes [34,35]. However,
theexpressionofTOX,whichmayalsoregulateTh-POKexpression
was not altered. By contrast, the higher affinity DO11.10 system had
less of a reduction in Th-POK and a larger reduction in expression of
Runx3, GATA3 and TOX. The significance of these differences is
not clear. Nevertheless, these data suggest that perhaps there is an
absolute amount of signal that is required to induce or maintain the
expression of Th-POK, following which CD4 lineage commitment is
Figure 10. Itk mediated signals intersect with TCR affinity to regulate the expression of Th-POK and the development of CD4
+ T
cells. (A) The ratios and percentages of CD4SP thymocytes in OT-II:OTII/Itk
2/2 (triangles) and DO11.10:DO11.10/Itk
2/2 (squares) mice were plotted
against the corresponding ratios of the expression of Th-POK in their DP thymocyte population. (B) Quantitative real-time RT-PCR for Th-POK in
sorted transgenic TCR
+ naı ¨ve splenic CD4
+ T cells (top left), sorted transgenic TCR
+ naı ¨ve CD4SP thymocytes (top right), sorted non-transgenic DP
thymocytes (bottom left) or sorted non-transgenic naı ¨ve splenic CD4
+ T cells (bottom right). Data are corrected for GAPDH expression and expressed
as fold over mRNA of the corresponding WT mice, which was set at 1 (n=3 with no significant difference observed).
doi:10.1371/journal.pone.0008891.g010
Itk Regulates ThPOK Expression
PLoS ONE | www.plosone.org 11 January 2010 | Volume 5 | Issue 1 | e8891fixed. However, in the presence of a low affinity TCR and reduced
signals in the absence of Itk, the frequency of cells that receive such





thymocytes and peripheral CD4
+ T cells express similar levels of Th-
POK supports this view, and suggests that those Itk
2/2 cells that
express threshold levels of Th-POK for CD4 differentiation are
allowed to proceed, but that this frequency is much lower than that
seen in the WT mice, hence the reduced numbers of mature CD4SP
in the absence of Itk. The lower levels of Th-POK expressed in those
remaining Itk
2/2 developing DP thymocytes may now allow
enhanced expression of Runx3, and accompanying increases in
Runx3 regulated genes Eomesodermin, Granzyme B and Perforin
[52,53,54]. Of course, it is possible that Itk derived signals combine
with TCR affinity to negatively regulate Runx3 such that in their
absence, Runx3 expression is elevated, suppressing Th-POK
expression and reducing CD4
+ T cell development [55]. Either
model would predict that on a non-transgenic background, the
affinity of the TCRs expressed by Itk null CD4
+ T cells would tend to
be ofhigher affinity so asto overcomethe reductionin TCR signals in
the absence of Itk.
We and others have previously shown that Itk is required for the
development of conventional CD8
+ T cells, while leaving intact
‘‘non-conventional’’ CD8
+ T cells that have a memory phenotype
and exhibit innate function [22,23,25]. In this paper, we show that
memory phenotype CD8
+ Tc e l l sc a ns t i l ld e v e l o pe v e ni nt h e
presence of afixed MHC class IIrestricted TCR transgenethat drives
CD4
+ T cell development, suggesting that the development of these
CD8
+ MP cells may be a consequence of impaired TCR signaling
(although it is possible that these TCR transgene positive CD8
+ T
cells also carry endogenous TCRs and were selected on those
receptors). Note that MHC class I restricted OT-1/Itk
2/2 mice
develop normal conventional CD8
+ T cell due to efficient selection in
the thymus of T cells carrying this transgenic TCR [23]. Alberola-Ila
and colleagues’ previous work on the influence of Lck and Ras/MAP
kinase pathways on CD4 and CD8 T cell commitment suggested that
MHCclassII-restrictedCD8
+Tc e l lst h a td e v e l o pi na ne n v i r o n m e n t
of reduced Lck signals behave as competent cytotoxic T cells, able to
kill target cells [4]. It was not determined whether the CD8
+ Tc e l l s
that developed in those systems were all conventional CD8 T cells.
The CD8
+ T cells that develop in OT-II/Itk
2/2 mice also express
high levels of perforin and granzyme B, and can degranulate
following stimulation (data not shown), all characteristics of cytotoxic
CD8
+ T cells. It is possible that the CD8
+ T cells that develop under
conditions of reduced Lck activity are also innate memory phenotype
cells. In the absence of Itk and in the environment of a low affinity
TCR such as the OT-II TCR, these cells may develop due to a
default differentiation program to CD8SP cells that results from
reduction in Th-POK expression and increase in Runx3 expression,
as has been suggested by the observed increase in CD8SP
development when Th-POK levels are reduced [56]. Whether these
cells would develop in the context of the transgene and knockout
crossed onto a RAG null background is not clear.
Although the discovery of Th-POK as a major commitment
factor for CD4 lineage commitment represented a huge advance
in our understanding of CD4 T cell development, signals that
regulate the expression of the factor are unknown. Our work
reported here shows that Itk plays a role in regulating this factor,
thus regulating the development of CD4
+ T cells. In addition, our
work connects signals emanating from the TCR, via Itk, and the
expression of specific genes that regulate lineage commitment,
suggesting a possible mechanism by which TCR signals can
regulate CD4/CD8 commitment.
High levels of Lck and ERK MAPK has been shown to lead to
enhanced CD4 T cell development to the detriment of CD8 T cell
development [4,5], while reduced activity of Lck, ZAP70 and ERK
leads to reduced CD4 T cell development, leaving CD8 T cell
development intact [4,5,6]. Our data here suggest that a Lck-Itk-
MAP kinase signaling pathway in double positive thymocytes may
modulate the development of CD4
+ T cells, with perhaps default
Figure 11. Itk mediated signals intersect with TCR affinity to regulate Runx3 regulated genes in naı ¨ve or conventional CD4
+ T cells.
Quantitative real-time RT-PCR for Perforin, Granzyme B and Eomesodermin in sorted transgenic TCR
hi CD4SP thymocytes from OT-II and OT-II/Itk
2/2
mice Data are corrected for GAPDH expression and expressed as fold over mRNA of the respective OT-II cells, which was set at 1 (n=3, *p,0.05).
Expression of these genes in sorted WT memory phenotype CD8
+ T cells are shown as a reference.
doi:10.1371/journal.pone.0008891.g011
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development of conventional vs. non-conventional or innate memory
phenotype CD8 T cell development). Our data also suggest that
components of the TCR signaling pathway may affect the lineage
choices of T cells dependent on the affinity of the TCR. Final
decisions on lineage choice may thus be determined by the
combination of TCR affinity and strength of the TCR signals with
absolute levels of signaling determining lineage commitment choices.
Materials and Methods
Mice
We used WT or Itk
2/2 mice all on a C57BL/6 background,
between 6–12 weeks of age, which were kept in specific pathogen
free conditions. OT-II and DO11.10 transgenic mice were from
Jackson Labs (Bar Harbor, Maine) and bred in our lab. OT-II/
Itk
2/2 mice were generated by crossing Itk
2/2 mice to OT-II
transgenic mice. These mice were intercrossed, then backcrossed
.5 generations. DO11.10/Itk
2/2 mice were generated by crossing
Itk
2/2 mice on a BALB/c background (kind gift of Dr. Deborah
Fowell, University of Rochester [57]), to DO11.10 transgenic mice.
Tg(Lck-ItkDKin)Itk
2/2 and Tg(CD2-Itk)Itk
2/2 mice were generated
previously in our lab and were backcrossed to the C57BL/6
background .10 generations [27,28]. All experiments were
approved by the IACUC at Pennsylvania State University.
Antibodies and Flow Cytometry
Cells were incubated for half an hour at 4uC with antibodies in
100 ml PBS/2% FBS, followed by two washes in PBS/2% FBS for
surface staining. The following antibodies were purchased from BD
Pharmingen and used as suggested by the manufacturer (BD
Pharmingen, San Diego, California): anti-CD8-FITC, Va2-PE,
Vb5-FITC, CD44-Cychrome, CD5-PE, CD45.2-FITC, IL-4-PE,
CD122-PE,and IFNc-PE-Cy7.Anti-CD4-ECDwasfromInvitrogen
(Carlsbad, California) and anti-murine-Bcl-2-PE was from Santa
Cruz Biotechnology (Santa Cruz, California). Intracellular staining of
Bcl-2 was carried out using a Fixation/Permeabilization kit from BD
Pharmingen (San Diego, California). Cells were analyzed using a
FC500 Cytometer from Beckman Coulter (Fullerton, California).
Quantitative Real-Time PCR Analysis
TCR
hi DP thymocytes, CD4SP thymocytes or naı ¨ve splenic
CD4
+ were sorted from the thymus of transgenic OT-II, OT-II/
Itk
2/2, DO11.10 and DO11.10/Itk
2/2 mice using a Cytopeia
Cell Sorter (Cytopeia Inc., Seattle, WA). Total RNA was prepared
from sorted cells using RNease mini kit (Qiagen Sciences,
Maryland). cDNA was generated using You Prime First-Strand
beads (GE Healthcare, Buckinghamshire, UK), and quantitative
PCR was performed using primer/probe sets for Th-POK, TOX,
Runx3, GATA3, Eomesodermin, Granzyme B and Perforin
(Applied BioSystems, Branchburg, New Jersey), with GAPDH as
a housekeeping gene. Data was analyzed using the DD
Comparative CT (threshold cycle) method and normalized to
GAPDH and relative to a calibrator sample. The relative gene
expression levels were then determined by comparing to the
expression found in the transgenic TCR
hi OT-II or TCR
hi
DO11.10 DP populations, which were set as 1.
In Vitro Analysis of Cytokine Secretion
Spleens were removed from mice and total splenocytes from
OT-II and OT-II/Itk
2/2 mice were cultured with 1 mg/ml
OVA323–339 peptide (Research Genetics, Huntsville, AL) for 7
days. Dead cells were removed using lympholyte-M (Cedarlane
Laboratories, Burlington, NC), and viable cells then stimulated
with OVA (1 mg/ml) for 6 hours in the presence of Brefeldin A
(10 mg/ml), followed by analysis of cytokine secretion by
intracellular cytokine staining. In some cases, cells were stimulated
with PMA and Ionomycin for 6 hours in the presence of Brefeldin
A (10 mg/ml), followed by analysis of cytokine secretion by
intracellular cytokine staining.
Statistical Analysis
Data was analyzed using Prizm, and significance determined
using Students’ t test, with a value of p,0.05 considered
statistically significant.
Supporting Information
Figure S1 Expression of transgenic TCR on OT-II and
D011.10 thymocytes. Thymocytes from TCR transgenic OT-II,
OT-II/Itk
2/2, D011.10 or D011.10/Itk
2/2 mice were stained
with antibodies against CD4, CD8a and TCRVa2 (for OT-II) or
anti-KJ-126 (for D011.10), and TCR transgene expression
analyzed on CD4SP and CD8SP cells. WT backgrounds are
indicated by solid lines and Itk
2/2 background by dashed lines.
Found at: doi:10.1371/journal.pone.0008891.s001 (3.32 MB TIF)
Figure S2 Normal expression of Bcl-2 in TCR transgenic CD4
and CD8 SP thymocytes in OT-II mice the absence of Itk.
Thymocytes from TCR transgenic OT-II and OT-II/Itk
2/2 were
stained with CD4, CD8a, TCRVb5 and intracellular Bcl-2.
Histograms of Bcl-2 expression on DP, transgenic TCR
hiDP,
transgenic TCR
hiCD4SP and transgenic TCR
hiCD8SP from OT-
II (solid line) and OT-II/Itk
2/2 (dashed line) are shown (filled
histogram: nonspecific isotope staining). A minimum of 10 mice of
each genotype with 6–12 weeks of age were analyzed, and
representative flow profiles are shown.
Found at: doi:10.1371/journal.pone.0008891.s002 (1.46 MB TIF)
Figure S3 Normal survival of TCR transgenic CD4 and CD8
SP thymocytes in OT-II mice in the absence of Itk. Thymocytes
from transgenic OT-II and OT-II/Itk
2/2 were stained with CD4,
CD8a and TCRVb5, along with 7AAD and Annexin V.




hi DP, CD4SP and CD8SP are shown. The
percentage of Annexin V
+ cells for each subset is presented. A
minimum of 4 mice of each genotype with 6–12 weeks of age were
analyzed, and representative flow diagrams are shown.
Found at: doi:10.1371/journal.pone.0008891.s003 (2.15 MB TIF)
Figure S4 CD69 expression and gene expression profiles of
naı ¨ve (conventional) CD4SP thymocytes in the OT-II transgenic
system. Thymocytes from TCR transgenic OT-II and OT-II/
Itk
2/2 were stained with antibodies against CD4, CD8a and
CD69. Representative histograms of CD69 expression on gated
CD4/CD8 DP thymocytes are shown for OT-II (solid line) and
OT-II/Itk
2/2 (dashed line).
Found at: doi:10.1371/journal.pone.0008891.s004 (3.91 MB TIF)
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